Novartis Rethinks Gross sales Technique for New Ldl cholesterol Drug Launch


Novartis AG guess huge on its new cholesterol-busting drug. To beat the tough marketplace for new coronary heart medicines, it’s pursuing an unconventional technique that turns the normal drug launch on its head.

Slightly than looking for to seize the eye of sufferers and profitable assist from particular person physicians, the Swiss pharmaceutical big is specializing in the individuals who run massive hospital methods. Its pitch: A big-scale rollout of the drug, known as Leqvio, may avert hundreds of coronary heart assaults and strokes.